568 - State-of-the-Art Session
Joint TTS-AST-ASTS-ESOT: Advancing Transplant Therapeutics and Innovation (Videos Available)

Wednesday July 04, 2018 | 14:30 to 16:00
Room: N-115/116
Track: N/A


Joint TTS-AST-ESOT Session

Objectives: this session will update attendees on recent efforts to revitalize and reinvigorate clinical trials in solid organ transplantation.  In this session, attendees will:

  1.  Learn about the role of private public partnerships with government approval agencies in forging new pathways of drug approval not previously utilized
  2. Identify and learn about clinical trial endpoints developed through consensus of investigators and patients
  3. Learn about the design of future trials that may incorporate new endpoints such as patient reported outcomes, biomarkers, composite end points, and specific high risk groups



Dr. Roslyn B. Mannon, United States
The Transplant Therapeutics Consortium: Update on progress and goals

Allison Tong, Australia
Solidifying endpoints in clinical trials: SONG Tx Initiative (Video Available)

Prof. Stefan Schneeberger, Austria
Challenges involved in developing new endpoints for clinical trials

Prof. Maarten Naesens, Belgium

© 2023 TTS2018